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Abstract
Chronic pain conditions are often co-morbid with alcohol abuse. “Self-medication” with alcohol 
introduces a host of problems associated with the abuse of alcohol which over time has the 
potential of exacerbating the painful condition. Despite the prevalence of chronic pain being 
associated with alcohol abuse, rodent models which mimic the co-morbid conditions are lacking. 
In the present study, we model osteoarthritis (OA) in C57BL/6J mice by surgically destabilizing 
the medial meniscus (DMM). Sham operated mice served as controls. Thirteen weeks after 
surgery, DMM but not sham operated mice exhibited pronounced incapacitance of the surgically-
manipulated hindlimb compared to the non-surgically manipulated hindlimb. At this time, the 
mice were exposed to the two-bottle ethanol choice, beginning with 2.5% with a gradual 
increasing to 20%. Compared to sham controls, DMM mice consumed more EtOH and preferred 
EtOH over water at the 20% EtOH concentration. Histological analysis verified that the DMM 
mice exhibited significant damage to the articular cartilage and osteophyte growth compared to 
sham controls and these measures of the severity of OA correlated with the amount of ethanol 
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intake. Thus, the combination of the DMM model of OA with the enhanced two-bottle ethanol 
choice is a potential preclinical approach in mice by which the basis of the co-morbid association 
of alcohol abuse and chronic pain conditions can be explored.
1. Introduction
Chronic pain and alcohol abuse are tremendous burdens to individuals and to society. 
Frequently, individuals resort to “self-medication” with alcohol in an effort to relieve pain. 
This is readily apparent in clinical studies which have demonstrated that approximately 28% 
of patients with chronic pain disorders such as arthritis also abuse alcohol [17]. It is reported 
that younger males suffering from arthritis are much more likely than females to self-
medicate with alcohol and that this correlates with pain continuity, frequency, depression, 
frustration and marital status [17]. While much effort has been exerted trying to investigate 
the underpinning causes of chronic pain and alcohol abuse separately, relatively few studies 
have investigated how chronic pain might instigate alcohol abuse.
While acute alcohol has been demonstrated to provide an analgesic effect under some 
painful conditions [6; 19; 20], this use of alcohol is greatly limited due to acute intoxication, 
addiction/chronic abuse, and the introduction of maladaptations which can lead to 
cardiovascular disease, cancer, cirrhosis and other medical problems. Chronic alcohol abuse 
can also lead to tolerance which can minimize its analgesic action and exacerbate allodynic 
and nociceptive disorders [for review see 8; 11]. Furthermore, in trauma centers, patients 
who abuse alcohol are more susceptible to harmful drug interactions [1].
One limiting factor that has contributed to a lack of examination of the basis of the co-
morbidity of chronic pain and alcohol abuse is the lack of an appropriate rodent model. The 
present study was designed to determine if using a combination of a well-established model 
of chronic pain and alcohol preference/consumption in mice – surgical destabilization of the 
medial meniscus (DMM) [7; 9; 14; 16] and the two-bottle ethanol choice [2], respectively – 
is appropriate for studying chronic pain-induced ethanol intake. A positive outcome would 
allow further investigation of this approach as an appropriate avenue to investigate the basis 
of the co-morbidity of pain and alcohol intake that results in alcohol abuse clinically.
2. Materials and Methods
2.1 Animals
Ten C57BL/6J male mice (Jackson) were initially housed in groups of up to 4 in plastic-
bottomed cages. Animals were housed in a temperature- and humidity-controlled room 
under a 12:12 h light:dark cycle with lights on from 0700 to 1900 h. Access to food and 
water was provided ad libitum. Mice were group housed with up to 3 littermates until two 
weeks prior to incapacitance testing at which time they were individually housed. All in vivo 
experiments were conducted with a protocol approved by the Institutional Animal Care and 
Use Committee at The University of North Carolina at Chapel Hill. Animal use was carried 
out in strict accordance with the recommendations in the Guide for the Care and Use of 
Laboratory Animals of the National Institutes of Health.
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2.2 Destabilization of the medial meniscus and incapacitance testing
The DMM model of OA, initially established by Glasson et al. [9] was performed as 
previously described [14]. Mice were 12 weeks of age at the time of DMM or sham surgery. 
OA was induced by transection of the meniscotibial ligament in the right knee. The sham-
operated controls underwent the same surgery except that the meniscotibial ligament was not 
cut. Mice were allowed free activity in their home cages after surgery.
Four days prior to incapacitance testing, each mouse was habituated to the environment, 
handling and restraint necessary for performance of the test. On the test day, thirteen weeks 
after surgery, mice were assessed for incapacitance of the operated right hindleg as 
previously described [3] (Figure 1A). Weight bearing was measured by the downward 
pressure applied to plates of the Incapacitance Meter Tester (IITC Life Science, Woodland 
Hills, CA., USA). The mean weight (g) of the left and right side was measured over a 5 
second interval. Each measurement was repeated 10 times and the average difference in the 
load-bearing side with the non-surgical (contralateral) paw versus the surgical (ipsilateral) 
was calculated.
2.3 Two-bottle ethanol choice
Immediately following the determination of incapacitance of DMM mice versus sham 
controls, we exposed both groups of mice to the two-bottle ethanol choice [2]. Mice had 
uninterrupted access to both water and ethanol throughout the 24 day trial. Initially, mice 
were exposed to a concentration of 2.5% ethanol for four days (days 1–4); the concentration 
of ethanol gradually increased to 5.0% (4 days; days 5–8), 10% (8 days; days 9–16) and 
20% (8 days; days 17–24). Each day, the bottles were weighed and placement of the two 
bottles were switched to control for place preference. Every week, the body weights of the 
mice were measured. At the end of the trial, mice were rapidly decapitated and their 
hindlimbs dissected for histological analysis.
2.4 Histological analysis
Hindlimbs from the operated side were dissected and processed for histological analysis as 
previously described [14]. In brief, hematoxylin and eosin and safranin-O/fast green mid-
coronal sections of each stifle joint were obtained and one representative HE-stained section 
from each joint was graded by an evaluator (VU) blinded to group assignment. The 
evaluation included the Articular Cartilage Structure (ACS) score (0–12), synovial 
hyperplasia severity score in the medial compartment (0–3; 0 = 1 cell layer in synovium, 1 = 
2–3 cell layers, 2 = 4–5 cell layers, and 3 = 5 or more cell layers), and osteophyte score for 
the medial tibial compartment (0–3) [13]. An adjacent slide (~ 70 um apart) was stained with 
safranin O/fast green and the Safranin-O (Saf-O) staining score (0–12) [15] for the medial 
tibial compartment was obtained.
2.5 Data analysis
GraphPad Prism® (version 6.07) was used to statistically analyze all data. Incapacitance test 
data were analyzed using a Student’s unpaired t-test for differences between sham and 
DMM subjects. Alcohol consumption (g EtOH consumed per kg body weight) and 
preference (mL EtOH consumed per total mL liquid consumed) with the two bottle choice 
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were analyzed using two-way repeated measures analysis of variance (ANOVA). Repeated 
measures ANOVA were performed independently for the different concentrations of ethanol 
(2.5, 5.0, 10 and 20%). Alcohol consumption and preference data from day 24 at 20% EtOH 
concentration was not included in the final data set because of interruption of the night-time 
drinking cycle due to blood collection and breath analysis (data not shown). Bonferroni’s 
multiple comparisons test was used when appropriate. A P < 0.05 was considered 
significant. Correlation between the incapacitance versus OA histological analyses and 
grams of EtOH consumed / body weight versus OA histological analyses were determined 
using Pearson’s correlation coefficient. The grams of EtOH consumed in these analyses 
were the summed total over the entire 20% EtOH exposure. A P < 0.05 was considered 
significant.
3. Results
As a voluntary consummatory study, it was important to ensure that the body weight of the 
mice did not confound the volumetric intake of EtOH. Therefore, each week of the two-
bottle choice test the body weight of each mouse was recorded (grams) and compared 
between the sham and DMM groups. We found no statistical differences between the two 
groups at any of the time points [week 1: Sham = 32±1, DMM = 33±5 (P=0.4816, t=0.7380, 
df=8); week 2: Sham = 32±1, DMM = 33±5 (P=0.8042, t=0.2563, df=8); week 3: Sham = 
33±2, DMM = 35±5 (P=0.3837, t=0.9215, df=8).
3.1 DMM mice exhibit an increase in alcohol preference compared to sham surgery mice
Mice subjected to the DMM surgery exhibited pronounced incapacitance of their surgically-
impaired hindlimb compared to sham controls 13 weeks post-surgery (P=0.0016, t=4.664, 
df=8) as confirmed by a Student’s t-test (Figure 1B). The incapacitance of the mice 
correlated with certain measurements of the degree of OA severity in DMM and sham 
control mice, as measured with Safranin-O and hematoxylin and eosin staining (Figure 1C). 
Pearson’s product-moment correlation demonstrated no significant correlation between the 
change in weight (g) between the contralateral and ipsilateral paw and the scores for 
articular cartilage structure (r=0.6255, P=0.0531) (Figure 1D), but did reach statistical 
significance with Safranin-O staining (r=0.8522, P=0.0017) (Figure 1E), osteophyte score 
(r=0.8595, P=0.0014) (Figure 1F) and the score for synovial hyperplasia (r=0.7773, 
P=0.0081) (Figure 1G).
Immediately following confirmation of incapacitance, mice were subjected to a two-bottle 
ethanol choice of gradually increasing concentrations of EtOH (2.5, 5.0, 10 and 20%) 
(Figure 2). Two-way repeated measures ANOVA was performed on each concentration of 
EtOH. A significant interaction between DMM treatment and time was measured at 10 
(F7,56 = 3.812, P = 0.0019) and 20% EtOH (F6,48 = 4.827, P = 0.0006) for alcohol 
consumption (Figure 2A). A significant effect of DMM was measured at the 20% EtOH 
concentration (F1,8 = 15.95, P = 0.0050) and alcohol preference (F1,8 = 14.66, P = 0.0006) 
(Figure 2B). A significant increase in consumption of EtOH by DMM mice versus sham 
controls was confirmed on days 16 (P<0.001), 18 (P<0.0001), 20 (P<0.01), 21 (P<0.01) and 
22 (P<0.01) and preference for EtOH on days 18 (P<0.0001), 20 (P<0.05) and 22 (P<0.05) 
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with Bonferroni’s multiple comparison’s test. Importantly, no differences were measured in 
body weight or water consumption between the sham and DMM groups at any time point 
(data not shown).
3.2 Severity of osteoarthritis (OA) correlates with degree of alcohol consumption
Certain measurements of the OA severity in DMM and sham control mice, as measured with 
Safranin-O and hematoxylin and eosin staining, correlated with the amount of alcohol 
consumed. Pearson’s product-moment correlation confirmed a significant correlation 
between the grams of 20% EtOH consumed per kg body weight and the scores for articular 
cartilage structure (r=0.9608, P<0.0001) (Figure 3A), Safranin-O staining (r=0.8208, 
P=0.0036) (Figure 3B) and osteophyte score (r=0.8608, P=0.0048) (Figure 3C). The score 
for synovial hyperplasia did not correlate significantly with ethanol consumption (r=0.1742, 
P=0.6304) (Figure 3D). No significant correlation was found between incapacitance of the 
mice and the amount of ethanol consumed (r=0.5144, P=0.1282) (Figure 3E).
4. Discussion
In this study, we show that the DMM mouse model of OA induced a robust increase in EtOH 
intake and preference compared to sham controls. Mice which exhibit pronounced 
incapacitance of the surgically-impaired hindlimb proceeded to consume more ethanol per 
body weight at the highest concentration of EtOH (20%). Furthermore, significant 
correlations were demonstrated between EtOH intake and post-mortem analyses of articular 
cartilage damage and osteophyte growth –histological measurements which both determine 
the severity of the OA. This finding suggests the possibility that the degree of ethanol intake 
in mice can be predicted by the severity of OA.
A recent study by González-Sepúlveda et al. [10] in a mouse model of neuropathic pain 
demonstrated that partial sciatic nerve ligation also resulted in an increase in alcohol 
consumption and long-term anxiety- and depressive-like behaviors. However, consumption 
of alcohol did not attenuate nociceptive behaviors in this protocol. In a separate study by 
Smith et al. [18], no increase in EtOH preference with the two-bottle choice and a mouse 
model of chronic, inflammatory pain was observed. In this latter study, administration of 
Complete Freunds Adjuvant to the hindpaw did not induce an increase in ethanol intake. 
Taken together, current data from this and other studies suggest that mouse models of 
DMM-induced OA and partial sciatic nerve ligation-induced neuropathic pain, but not 
chronic inflammatory pain, result in an increase in alcohol intake in mice. Thus, these mouse 
models could possibly allow suitable studying of the co-morbidity of chronic pain and 
alcohol abuse.
In contrast to the study by González-Sepúlveda et al. [10], our present investigation did not 
assess whether EtOH ingestion reduced nociceptive behaviors. In a DMM study, anti-
nociception would have been confirmed with reduced incapacitance of the DMM-impaired 
hindlimb. However, because this was a voluntary consummatory experiment, measuring 
changes in incapacitance after EtOH consumption would not have been suitable. The amount 
of EtOH consumed would need to be controlled in order for such a measurement of 
incapacitance across subjects to be valid which is not feasible with voluntary consumption. 
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Furthermore, while most EtOH consumption took place during the dark cycle, there were 
stark individual differences in the exact time of consumption. Therefore, the time of 
consumption would need to be controlled for to examine the analgesic effects of alcohol. 
Finally, the major finding of this study is that chronic osteoarthritic pain leads to enhanced 
EtOH consumption and this is not diminished by the lack of incapacitance measurements 
after EtOH consumption. However, this could make for a future direction whereby alcohol is 
involuntarily consumed via gavage or an intra-intestinal catheter. Then, measurements on the 
effects of alcohol on incapacitance could be made in a controlled manner and at the same 
time determine if an increase in alcohol consumption underpins an increase in the severity of 
OA or vice versa. In the study by González-Sepúlveda et al., they showed no significant 
reduction in nociceptive behaviors with alcohol – a finding which is in contrast to both 
rodent [5] and human studies [6; 19; 20]. However, in addition to introducing several 
maladaptations including cancer, liver disease, etc., chronic alcohol intake has been 
demonstrated to exacerbate painful conditions over time [1; 4]. Therefore, a wide breadth of 
scientific literature concludes that alcohol should not be used as an analgesic.
One possible confounding aspect of our data is the low EtOH intake for the sham group of 
C57BL/6 mice. Studies with this strain of mice have shown consumption as high as 15 g 
EtOH per kg body weight [21]. However, a consideration must be made to the age of the 
mice at the time of exposure to the two-bottle choice. In mice, adult naïve mice consume 
less EtOH than adolescents [12]. At the time of the two-bottle choice in our paradigm, mice 
are 23–25 weeks of age and lasts until 28 weeks of age. Therefore, we presume that the 
decrease in EtOH consumption in the sham controls compared to other studies is due to the 
age of the animals.
In summary, we demonstrate that following induction of OA using DMM surgery, a well 
characterized model of OA in mice, there is a large increase in alcohol preference compared 
to sham surgery mice. In addition to having positive face validity to the human co-morbid 
conditions of osteoarthritis and chronic alcohol abuse, it also can serve as a model for 
chronic pain-induced alcohol consumption in general. With this model, investigations can be 
made with novel analgesics that aim to eliminate or reduce alcohol abuse in chronic pain 
patients. Given the enormous burden to individuals and society, further studies which utilize 
this model to decipher the mechanisms of chronic pain-induced alcohol consumption are 
warranted.
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Incapacitance testing of mice after surgical destabilization of the medial meniscus (DMM) 
or sham control surgery. (A) Timeline of in vivo experiments: 13 weeks after DMM or sham 
surgery, incapacitance of the hindlimb was measured and the two-bottle ethanol choice over 
3.5 weeks (24 days) commenced. (B) Measurement of incapacitance of the surgically-
impaired DMM hindlimbs compared to sham controls. N=5. **P<0.01. (C) Histological 
evaluation of cartilage damage (left; Safranin O/fast green staining), osteophyte growth 
(middle; HE staining) and synovial hyperplasia (right; HE staining) on the hindlimb of 
DMM and sham-operated mice. Correlation analyses of incapacitance of surgically-
manipulated hindlimb with (D) articular cartilage structure score, (E) Safranin-O staining 
score, (F) osteophyte score but not (G) synovial hyperplasia. N=5 (correlation graphs show 
both Sham and DMM data points). **P<0.01.
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Measurements of the (A) consumption of ethanol and (B) preference of ethanol versus water 
in DMM and sham-operated mice over the course of the two-bottle choice. Mice were given 
the choice between water and 2.5 (days 1–4), 5.0 (days 5–8), 10 (days 9–16), and 20% (days 
17–23) EtOH. DMM mice consumed greater quantities of ethanol per kg of body weight at 
days 16, 18, 20, 21 and 22 and showed a greater preference for ethanol on days 18, 20 and 
22 compared to sham controls. N=5. **** P<0.0001, ***P<0.001. **P<0.01, *P<0.05.
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The amount of 20% EtOH consumed correlated significantly with (A) articular cartilage 
structure score, (B) Safranin-O staining score, (C) osteophyte score but not (D) synovial 
hyperplasia. The amount of 20% EtOH consumed did not correlate significantly with (D) 
incapacitance of the surgically-manipulated hindlimb. N=5 (correlation graphs show both 
Sham and DMM data points). **** P<0.0001, **P<0.01.
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